Wells Fargo Maintains Overweight on Enovis, Raises Price Target to $37
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and raises the price target from $33 to $37.
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and raises the price target from $33 to $37.